Trademark: 97283350
Word
HEFAVI
Status
Registered
Status Code
700
Status Date
Tuesday, March 28, 2023
Serial Number
97283350
Registration Number
7012108
Registration Date
Tuesday, March 28, 2023
Mark Type
4000
Filing Date
Thursday, February 24, 2022
Published for Opposition
Tuesday, January 10, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 28, 2023
Notice Of Registration Confirmation Emailed
Mar 28, 2023
Registered-Principal Register
Jan 10, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2023
Published For Opposition
Dec 21, 2022
Notification Of Notice Of Publication E-Mailed
Dec 8, 2022
Approved For Pub - Principal Register
Dec 7, 2022
Assigned To Examiner
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 2, 2022
New Application Office Supplied Data Entered
Feb 28, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24